Submitted by Anonymous (not verified) on 4 October 2024 - 14:42
Opinion/decision on a Paediatric investigation plan (PIP): Xofluza, Baloxavir marboxil, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0359/2023
Source: